NeuroPace Market Cap

NeuroPace has a market cap or net worth of $233.88 million as of May 17, 2024. Its market cap has increased by 106.79% in one year.

Market Cap

233.88M

Enterprise Value

247.90M

1-Year Change

106.79%

Ranking

#3559

Market Cap Chart

Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $233.88M, a decrease of -40.53%. That is a compound annual growth rate of -15.57%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	235.00M	-4.59%
May 16, 2024	246.30M	-5.20%
May 15, 2024	259.80M	6.13%
May 14, 2024	244.80M	-0.12%
May 13, 2024	245.10M	0.25%
May 10, 2024	244.50M	6.63%
May 9, 2024	229.30M	-36.74%
May 8, 2024	362.50M	-3.85%
May 7, 2024	377.00M	-1.26%
May 6, 2024	381.80M	-1.24%
May 3, 2024	386.60M	-1.88%
May 2, 2024	394.00M	-0.51%
May 1, 2024	396.00M	7.55%
Apr 30, 2024	368.20M	-3.99%
Apr 29, 2024	383.50M	1.05%
Apr 26, 2024	379.50M	3.07%
Apr 25, 2024	368.20M	-4.21%
Apr 24, 2024	384.40M	-3.20%
Apr 23, 2024	397.10M	0.08%
Apr 22, 2024	396.80M	0.13%
Apr 19, 2024	396.30M	-0.13%
Apr 18, 2024	396.80M	1.82%
Apr 17, 2024	389.70M	-2.09%
Apr 16, 2024	398.00M	4.79%
Apr 15, 2024	379.80M	-0.76%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Coherus BioSciences	251.82M
Generation Bio Co.	250.15M
Utah Medical Products	248.86M
Adaptimmune Therapeutics	248.60M
Foghorn Therapeutics	248.27M
Pyxis Oncology	246.15M
uniQure	245.66M
AirSculpt Technologies	244.67M

Market Cap Rankings